Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
Expert Review of Clinical Immunology|May 19, 2010
Dendritic cell-based therapy in Type 1 diabetes mellitusBrett Phillips, Nick Giannoukakis, Massimo TruccoPediatric Diabetes|June 11, 2008
Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyondNick Giannoukakis, Brett Phillips, Massimo TruccoClinical & Developmental Immunology|July 26, 2011
Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Brett Phillips, Massimo Trucco, Nick GiannoukakisCurrent Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and preventionNick Giannoukakis, Massimo Pietropaolo, Massimo TruccoContributions to Nephrology|April 9, 2008
Renal diseases as targets of gene therapyBrett Phillips, Nick Giannoukakis, Massimo TruccoAdvanced Drug Delivery Reviews|December 7, 2007
Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetesLorenzo Pasquali, Nick Giannoukakis, Massimo TruccoDiabetes|March 16, 2022
Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2-Infected Young Individuals: Is It Type 1 Diabetes?Massimo Pietropaolo, Peter Hotez, Nick GiannoukakisClinical Immunology (Orlando, Fla.)|March 31, 2015
A brief glimpse over the horizon for type 1 diabetes nanotherapeuticsYesica Garciafigueroa, Massimo Trucco, Nick GiannoukakisThe Review of Diabetic Studies : RDS|June 28, 2013
In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetesValentina Di Caro, Nick Giannoukakis, Massimo TruccoDiabetes|September 24, 2011
FoxO6 integrates insulin signaling with gluconeogenesis in the liverDae Hyun Kim, German Perdomo, Ting Zhang, et al.Pageof 9